Form 8-K · Item 4.01 · Auditor change

Praxis Precision Medicines, Inc.: auditor change, Ernst & Young LLP to KPMG LLP

Praxis Precision Medicines, Inc. reported in a Form 8-K filed July 2, 2026, that on June 29, 2026, Ernst & Young LLP was dismissed as its certifying accountant, and KPMG LLP was engaged.

In the filing's words

On June 29, 2026, the Audit Committee of the Board of Directors (the "Audit Committee") of Praxis Precision Medicines, Inc. (the "Company") approved the dismissal of Ernst & Young LLP ("EY") as the Company's independent registered public accounting firm, effective as of that date.
there were no: (i) disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) with EY on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure
On June 29, 2026, the Audit Committee approved the engagement of KPMG LLP ("KPMG") as the Company's new independent registered public accounting firm, effective as of that date.

Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.

CompanyPraxis Precision Medicines, Inc.
TickerPRAX
Form and item8-K, Item 4.01
Filed with the SECJuly 2, 2026
What the filing statesdismissed, engaged
Former accountantErnst & Young LLP
New accountantKPMG LLP
Date of the changeJune 29, 2026
Disagreementsnot stated
Auditor's letterExhibit 16 on sec.gov
Accession number0001104659-26-080356
SEC CIK0001689548

Praxis Precision Medicines, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed July 2, 2026. The filing's own words are quoted above.

Sources

  • sec.gov · SEC filing, Form 8-K, Item 4.01 · accessed 2026-10-23
  • sec.gov · Exhibit 16, the former accountant's letter

More: all auditor changes · Something wrong? Send a correction with the primary source.